Cerus reported $19.33M in Selling and Administration Expenses for its fiscal quarter ending in December of 2024.





Selling And Administration Expenses Change Date
Cerus USD 19.33M 1.55M Dec/2024
GRIFOLS EUR 281M 5.7M Mar/2026
Haemonetics USD 109.15M 7.54M Dec/2025
Neogen USD 98.5M 9M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Quidel USD 199.3M 4.9M Mar/2026
Rockwell Medical USD 4.04M 330K Jun/2024
STAAR Surgical USD 38.64M 299K Mar/2026
Terumo JPY 114.81B 9.55B Mar/2026
Utah Medical Products USD 2.61M 741K Dec/2025